General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED STATEMENTS OF CASH FLOWS    
Net Loss $ (85,743,970) $ (31,184,596)
Adjustments to Reconcile Net Loss to Cash Used in Operations    
Depreciation Expense 1,218,796 613,329
Stock-Based Compensation 1,379,400 651,329
Class A and Class D Preferred Returns 6,107,441 5,577,812
Amortization of Discount from Issuance of Debt 931,958  
Mark-to-Market Adjustment For Warrants 12,063,265  
Amortization of Debt Origination Fees 525,783  
Net Change in ROU Assets and Liabilities 379,235 (57,496)
Premium Deficiency Reserve 4,600,000 (1,304,962)
Changes in Assets and Liabilities    
Accounts Receivable, Net 54,602 (477,983)
Health Plan Settlements Receivable / Premiums Receivable (7,417,477) (22,312,352)
Other Current Assets 2,667,427 (53,293)
Accounts Payable and Accrued Expenses 3,606,729 5,822,494
Accrued Payroll (1,842,877) 1,644,954
Accrued Interest 3,952,044 1,201,458
Health Plan Settlements Payable (483,657) 938,965
Claims Payable 18,173,851 32,295,208
Net Cash Used in Operations (39,827,450) (6,645,131)
Investing Activities    
Purchases of Property, Plant and Equipment (2,990,130) (2,232,652)
Acquisitions (5,014,500)  
Notes Receivable, Net 120,463 336,130
Net Cash Used in Investing Activities (7,884,167) (1,896,521)
Financing Activities    
Issuance (Redemption) of Member Units   (180,000)
Issuance of Long-Term Debt 12,750,000 158,134
Repayment of Long-Term and Short-Term Debt (67,216)  
Loan Origination and Closing Fees (191,250)  
Net Cash Provided by Financing Activities 12,491,534 (21,866)
Net Change in Cash and Restricted Cash (35,220,083) (8,563,519)
Cash and Restricted Cash at Beginning of Period 39,902,947 32,904,848
Cash and Restricted Cash at End of Period 4,682,864 24,341,328
Supplemental Disclosures of Cash Flow Information:    
Cash Paid for Interest 1,707,705 $ 312,185
Accrued Costs for Internally Developed Technology (in Process) $ 123,027